| Primary |
| Hypertonic Bladder |
26.7% |
| Urinary Incontinence |
11.0% |
| Hypertension |
10.1% |
| Incontinence |
7.1% |
| Pollakiuria |
7.1% |
| Bladder Disorder |
6.1% |
| Ill-defined Disorder |
4.9% |
| Depression |
3.7% |
| Diabetes Mellitus |
3.1% |
| Drug Use For Unknown Indication |
2.8% |
| Blood Cholesterol Increased |
2.5% |
| Pain |
2.5% |
| Rheumatoid Arthritis |
2.1% |
| Micturition Urgency |
1.8% |
| Dyspnoea |
1.5% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Micturition Disorder |
1.5% |
| Urge Incontinence |
1.5% |
| Anxiety |
1.2% |
| Bladder Spasm |
1.2% |
|
| Drug Ineffective |
35.7% |
| Dry Mouth |
15.1% |
| Urinary Retention |
5.0% |
| Constipation |
4.2% |
| Urinary Incontinence |
3.8% |
| Vision Blurred |
3.4% |
| Drug Effect Decreased |
2.9% |
| Dyspepsia |
2.9% |
| Headache |
2.9% |
| Dysuria |
2.5% |
| Hallucination |
2.5% |
| Pollakiuria |
2.5% |
| Urinary Tract Infection |
2.5% |
| Abdominal Pain Upper |
2.1% |
| Amnesia |
2.1% |
| Drug Hypersensitivity |
2.1% |
| Rash |
2.1% |
| Vomiting |
2.1% |
| Mental Status Changes |
1.7% |
| Neurogenic Bladder |
1.7% |
|
| Secondary |
| Drug Use For Unknown Indication |
26.4% |
| Hypertonic Bladder |
13.2% |
| Bladder Disorder |
6.8% |
| Urinary Incontinence |
6.0% |
| Hypertension |
5.8% |
| Pollakiuria |
5.6% |
| Product Used For Unknown Indication |
4.9% |
| Blood Cholesterol Increased |
4.1% |
| Cystitis Interstitial |
3.7% |
| Micturition Urgency |
3.5% |
| Incontinence |
3.3% |
| Diabetes Mellitus |
2.7% |
| Irritable Bowel Syndrome |
2.5% |
| Sleep Disorder |
2.1% |
| Arthritis |
1.9% |
| Chemotherapy |
1.6% |
| Dementia Alzheimer's Type |
1.6% |
| Prophylaxis |
1.6% |
| Depression |
1.4% |
| Gastrooesophageal Reflux Disease |
1.2% |
|
| Drug Ineffective |
23.6% |
| Urinary Tract Infection |
10.0% |
| Urinary Incontinence |
7.3% |
| Rash |
6.4% |
| Drug Hypersensitivity |
5.5% |
| Transient Ischaemic Attack |
5.5% |
| Vision Blurred |
5.5% |
| Dry Mouth |
4.5% |
| Chemotherapy |
2.7% |
| Drug Interaction |
2.7% |
| Feeling Abnormal |
2.7% |
| Hearing Impaired |
2.7% |
| Memory Impairment |
2.7% |
| Road Traffic Accident |
2.7% |
| Stevens-johnson Syndrome |
2.7% |
| Tremor |
2.7% |
| Urinary Retention |
2.7% |
| Vomiting |
2.7% |
| White Blood Cell Count Decreased |
2.7% |
| Coeliac Disease |
1.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
26.9% |
| Drug Use For Unknown Indication |
13.8% |
| Multiple Sclerosis |
11.5% |
| Hypertension |
6.0% |
| Pain |
5.8% |
| Depression |
5.3% |
| Osteoporosis |
3.9% |
| Rheumatoid Arthritis |
2.8% |
| Anxiety |
2.7% |
| Urinary Incontinence |
2.5% |
| Gastrooesophageal Reflux Disease |
2.4% |
| Blood Cholesterol Increased |
2.3% |
| Diabetes Mellitus |
2.3% |
| Arthritis |
2.2% |
| Asthma |
1.7% |
| Multiple Myeloma |
1.6% |
| Bladder Disorder |
1.6% |
| Type 2 Diabetes Mellitus |
1.5% |
| Insomnia |
1.5% |
| Hormone Replacement Therapy |
1.5% |
|
| Weight Decreased |
14.0% |
| Vomiting |
12.0% |
| Urinary Tract Infection |
10.5% |
| Weight Increased |
8.5% |
| Nausea |
5.8% |
| Pain |
4.4% |
| Death |
4.0% |
| Vision Blurred |
3.9% |
| Drug Ineffective |
3.8% |
| Pneumonia |
3.7% |
| Headache |
3.5% |
| Tremor |
3.5% |
| White Blood Cell Count Decreased |
3.5% |
| Myocardial Infarction |
3.1% |
| Pyrexia |
2.9% |
| Pulmonary Embolism |
2.7% |
| Wheezing |
2.7% |
| Urinary Incontinence |
2.6% |
| Oedema Peripheral |
2.5% |
| Rash |
2.5% |
|
| Interacting |
| Product Used For Unknown Indication |
47.6% |
| Dementia Alzheimer's Type |
19.0% |
| Urinary Incontinence |
19.0% |
| Hypertonic Bladder |
9.5% |
| Blood Potassium Decreased |
4.8% |
|
| Drug Interaction |
53.8% |
| Urinary Incontinence |
15.4% |
| Urinary Tract Infection |
15.4% |
| Hypertonic Bladder |
7.7% |
| Nausea |
7.7% |
|
